Russian Medical Inquiry
(RMZh. Meditsinskoe Obozrenie) ISSN 2587-6821 (Print), 2686-9918 (Online)

Long-term experience of surgical removal of iridociliary tumors followed by iridolenticular diaphragm implantation

VAK

Scopus

E-libraryDimensions

russian citation indexULRICHS

roaddoaj

CyberleninkaGoogle Scholar

vinitiResearch4life

MendeleyScilit

РГБWhite list




Open accessCrossrefAntiplagiat

RMJ.ru




DOI: 10.32364/2311-7729-2025-25-Suppl-5

A.A. Yarovoy, N.P. Sobolev, A.V. Shatskikh, A.D. Matyaeva

S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation

Background: surgical removal of iridociliary tumors is a top-priority method of organ-preserving treatment of anterior intraocular neoplasms. The technique may lead to negative consequences such as impaired diaphragmatic iris function and lens opacity followed by vision impairment, optical aberrations and photophobia. Iridolenticular diaphragm implantation that improves a functional result, cosmetic effect and patients' social adaptation, is the most relevant method to manage abovementioned conditions.

Aim: to determine an effect of block excision of iridociliary tumors followed by delayed implantation of iridolenticular diaphragm on a risk for recurrence of a malignant neoplasm, visual acuity and quality.

Materials and Methods: from 2004 to 2024, 26 patients underwent block excision of various volume followed by optical reconstructive surgical rehabilitation by implantation of artificial iris or iridolenticular diaphragm in the S. Fyodorov Eye Microsurgery Federal State Institution.

Results: block excision resulted in significantly decreased best corrected visual acuity. Along with this, photophobia and optical aberrations were reported in all patients. After phacoemulsification with implantation of iridolenticular diaphragm, visual acuity increased in 22 (85%) patients, and it decreased in 3 (11%) patients. The parameter remained unchanged in 1 (4%) patient. Photophobia and optical aberrations resolved. Several complications such as macular edema (n=3; 11%), secondary glaucoma (n=2; 8%), acute iridocyclitis (n=2; 8%), acute endophthalmitis (n=1; 4%), and dislocation of iridolenticular diaphragm into the vitreal cavity (n=1; 4%) were reported. During the entire follow-up (13 — 243 months), a recurrent melanoma was detected in 1 case only. No distant metastases were reported.

Conclusion: block excision of iridociliary neoplasms leads to a decreased quality of vision and life due to postoperative iris colobomas. Optical reconstructive surgery of ocular structures can improve visual functions without an increased risk of tumor recurrence.

Keywords: iridociliary tumors, block excision, iridolenticular diaphragm, surgical removal.

For citation: Yarovoy A.A., Sobolev N.P., Shatskikh A.V., Matyaeva A.D. Long-term experience of surgical removal of iridociliary tumors followed by iridolenticular diaphragm implantation. Russian Journal of Clinical Ophthalmology. 2025;25(Special Issue):37–42 (in Russ.). DOI: 10.32364/2311-7729-2025-25-Suppl-5

About the authors:

Andrey A. Yarovoy — Dr. Sc. (Med.), Head of the Department of Ophthalmo-oncology and Radiotherapy, S. Fyodorov Eye Microsurgery Federal State Institution; 59a, Beskudnikovskii blvd., Moscow, 127486, Russian Federation; ORCID iD 0000-0003-2219-7054

Nikolay P. Sobolev— Dr. Sc. (Med.), Chief Medical Officer of S. Fyodorov Eye Microsurgery Federal State Institution; 59a, Beskudnikovskii blvd., Moscow, 127486, Russian Federation; ORCID iD 0000-0003-3413-1458

Anna V. Shatskikh — C. Sc. (Med.), Pathologist, Head of Eye Pathology and Histology Laboratory, S. Fyodorov Eye Microsurgery Federal State Institution; 59a, Beskudnikovskii blvd., Moscow, 127486, Russian Federation; ORCID iD 0000-0002-3437-8162

Angelina D. Matyaeva — Ophthalmologist, Postgraduate Student, S. Fyodorov Eye Microsurgery Federal State Institution; 59a, Beskudnikovskii blvd., Moscow, 127486, Russian Federation; ORCID iD 0000-0001-7543-619X

Contact information: Angelina D. Matyaeva, e-mail: matyaeva.lina@yandex.ru

Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.

There is no conflict of interest.

Received 03.02.2025.

Revised 26.02.2025.

Accepted 21.03.2025.


References
1. Shields J.A., Shields C.L. Intraocular tumors: an atlas and textbook. PHILLY: Lippincott Williams & Wilkins; 2015.
2. Rusňák Š., Hecová L., Kasl Z. et al. Therapy of uveal melanoma A Review. Cesk Slov Oftalmol. 2020;77(1):1–13. DOI: 10.31348/2020/10
3. Chattopadhyay C., Kim D.W., Gombos D.S. et al. Uveal melanoma: From diagnosis to treatment and the science in between. Cancer. 2016;122(15):2299–2312. DOI: 10.1002/cncr.29727
4. Schmelter V., Heidorn S., Muacevic A. et al. Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma. Sci Rep. 2021;11(1):5685. DOI: 10.1038/s41598-021-84290-x
5. Саакян С.В., Амирян А.Г., Вальский В.В., Миронова И.С. Брахитерапия увеальной меланомы передней локализации. Вестник офтальмологии. 2015;131(2):5–12. DOI: 10.17116/oftalma201513125-11Saakian S.V., Amirian A.G., Valsky V.V., Mironova I.S. Plaque radiotherapy for anterior uveal melanomas. Russian Annals of Ophthalmology. 2015;131(2):5–12 (in Russ.). DOI: 10.17116/oftalma201513125-11
6. Shields C.L., Naseripour M., Shields J.A. et al. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications. Am J Ophthalmol. 2003;135(5):648–656. DOI: 10.1016/s0002-9394(02)02241-9
7. Линник Л.Ф. Хирургическая тактика удаления опухолей сосудистого тракта. Офтальмохирургия. 2006;(4):17–23.Linnik L.F. Surgical tactics for removing tumors of the vascular tract. Ophthalmosurgery. 2006;(4):17–23 (in Russ.).
8. Mirzayev I., Gündüz A.K., Okçu Heper A. Partial lamellar sclerouvectomy surgery for anteriorly located uveal tumour resection: a 20-year experience. Eye (Lond). 2022;36(5):969–977. DOI: 10.1038/s41433-021-01545-7
9. Naumann G.O., Rummelt V. Block excision of tumors of the anterior uvea. Report on 68 consecutive patients. Ophthalmology. 1996;103(12):2017–2027. DOI: 10.1016/s0161-6420(96)30392-8
10. Линник Л.Ф. Удаление опухолей иридоцилиарной зоны с склеропластическим закрытием дефектов. В кн.: тезисы докладов «Опухоли и опухолеподобные заболе-вания органа зрения». 1998;105–106.Linnik L.F. Removal of tumors of the iridociliary zone with scleroplastic closure of defects. In the book: abstracts of reports "Tumors and tumor-like diseases of the organ of vision". 1998:105–106 (in Russ.).
11. Crawford A.Z., Freundlich S.E.N., Lim J., McGhee C.N.J. Endocapsular artificial iris implantation for iris defects: Reducing symptoms, restoring visual function and improving cosmesis. Clin Exp Ophthalmol. 2022;50(5):490–499. DOI: 10.1111/ceo.14083
12. Саакян С.В. Функциональные нарушения после хирургического лечения опухолей иридоцилиарной зоны и меры их предупреждения. РМЖ. Клиническая офтальмо-логия. 2001;1:18–20.Saakyan S.V. Functional disorders after surgical treatment of tumors of the iridociliary zone and measures to prevent them. RMJ. Clinical ophthalmology. 2001;1:18–20 (in Russ.).
13. Линник Л.Ф. Оперативное удаление иридоцилиарных опухолей: современные возможности восстановительных операций при помутнении хрусталика. В кн.: тезисы докладов VIII Съезда офтальмологов России. М.; 2005:506–507.Linnik L.F. Surgical removal of iridociliary tumors: modern possibilities of reconstructive surgery for clouding of the lens. In: abstracts of the VIII Congress of Ophthalmologists of Russia. M.; 2005:506–507 (in Russ.).
14. Линник Л.Ф. Реконструктивные операции при иридоцилиарных опухолях в сочетании с катарактой. В кн.: тезисы докладов «Опухоли и опухолеподобные заболева-ния органа зрения». 1998;106–108.Linnik L.F. Reconstructive surgery for iridociliary tumors in combination with cataracts. In: abstracts of reports "Tumors and tumor-like diseases of the organ of vision". 1998:106–108 (in Russ.).
15. Klauber S., Jensen P.K., Prause J.U., Kessing S.V. Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients. Acta Ophthalmol. 2012;90(2):122–126. DOI: 10.1111/j.1755-3768.2010.01889.x
16. Worst J.G., Los J.R. Iris reconstruction by coloboma repair. Ophthalmic Surg. 1989;20(11):790–793. PMID: 2616126
17. Линник Л.Ф. Реконструктивные оперативные вмешательства при опухолях сосудистого тракта. В кн.: тезисы докладов VI съезда офтальмологов УССР: тез. Одесса; 1978.Linnik L.F. Reconstructive surgical interventions for tumors of the vascular tract. In: abstract of the VI Congress of Ophthalmologists of the Ukrainian SSR: thesis. Odessa; 1978 (in Russ.).
18. Бровкина А.Ф., Гундоров Р.А. Результат органосохранного лечения при опухолях иридоцилиарной области и показания к его применению. Офтальмологический журнал. 1978;6:426–431. PMID: 714350Brovkina A.F., Gundorova R.A. Results of organ-preserving treatment in tumors of the iridociliary region and the indications for its use. Oftalmol Zh. 1978;(6):426–431 (in Russ.). PMID: 714350
19. Андреева Т.А. Оптико-реконструктивные операции после блокэксцизий опухолей иридоцилиарной зоны. Дис. … канд. мед. наук. М.; 2010.Andreeva T.A. Optical reconstructive surgery after block excision of tumors of the iridociliary zone: thesis. M.; 2010 (in Russ.).
20. Burk S.E., Da Mata A.P., Snyder M.E. et al. Prosthetic iris implantation for congenital, traumatic, or functional iris deficiencies. J Cataract Refract Surg. 2001;27(11):1732–1740. DOI: 10.1016/s0886-3350(01)01124-5
21. Mavrikakis I., Mavrikakis E., Syam P.P. et al. Surgical management of iris defects with prosthetic iris devices. Eye (Lond). 2005;19(2):205–209. DOI: 10.1038/sj.eye.6701448
22. Nissen K., Skibsted S.P., Bagger M.M. et al. Outcome of combined cataract surgery and iris prosthesis implantation in iris melanoma patients previously treated with iridocy-clectomy: A national retrospective non-comparative case series. Acta Ophthalmol. 2024;102(5):581–589. DOI: 10.1111/aos.16610
23. Snyder M.E., Osher R.H., Wladecki T.M. et al. Results in Combined Cataract Surgery With Prosthetic Iris Implantation in Patients With Previous Iridocyclectomy for Iris Melanoma. Am J Ophthalmol. 2017;175:45–51. DOI: 10.1016/j.ajo.2016.11.013

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.


Previous article
Next article